APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nedaplatin Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Nedaplatin Injection Industry Growth and Trends Forecast to 2032

20 December 202595 pages

Choose your research edition.

Industry ResearchNedaplatin Injection Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Nedaplatin Injection Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Nedaplatin Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nedaplatin Injection Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Nedaplatin Injection Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Nedaplatin Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Nedaplatin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Nedaplatin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nedaplatin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Nedaplatin Injection include Nichi-Iko Pharmaceutical, Jilin Hengjin Pharmaceutical, Aosaikang Pharma, Simcere and Qilu Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Nedaplatin Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Nedaplatin Injection market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Nedaplatin Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Nedaplatin Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Nedaplatin Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Nedaplatin Injection Market by Company

Nichi-Iko Pharmaceutical

Jilin Hengjin Pharmaceutical

Aosaikang Pharma

Simcere

Qilu Pharma

Nedaplatin Injection Segment by Type

10mg

50mg

100mg

Nedaplatin Injection Segment by Application

Cervical Cancer

Esophageal Cancer

Ovarian Cancer

Testicular Cancer

Lung Cancer

Bladder Cancer

Other

Nedaplatin Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nedaplatin Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nedaplatin Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nedaplatin Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Nedaplatin Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Nedaplatin Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 10mg Table 2. Major Company of 50mg Table 3. Major Company of 100mg Table 4. Global Nedaplatin Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Nedaplatin Injection Sales by Type (2021-2026) & (K Units) Table 6. Global Nedaplatin Injection Sales Market Share in Volume by Type (2021-2026) Table 7. Global Nedaplatin Injection Sales by Type (2021-2026) & (US$ Million) Table 8. Global Nedaplatin Injection Sales Market Share in Value by Type (2021-2026) Table 9. Global Nedaplatin Injection Price by Type (2021-2026) & (US$/Unit) Table 10. Global Nedaplatin Injection Sales by Type (2027-2032) & (K Units) Table 11. Global Nedaplatin Injection Sales Market Share in Volume by Type (2027-2032) Table 12. Global Nedaplatin Injection Sales by Type (2027-2032) & (US$ Million) Table 13. Global Nedaplatin Injection Sales Market Share in Value by Type (2027-2032) Table 14. Global Nedaplatin Injection Price by Type (2027-2032) & (US$/Unit) Table 15. North America Nedaplatin Injection Sales by Type (2021-2026) & (K Units) Table 16. North America Nedaplatin Injection Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Nedaplatin Injection Sales by Type (2021-2026) & (K Units) Table 18. Europe Nedaplatin Injection Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Nedaplatin Injection Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Nedaplatin Injection Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Nedaplatin Injection Sales by Type (2021-2026) & (K Units) Table 22. Latin America Nedaplatin Injection Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Nedaplatin Injection Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Nedaplatin Injection Sales by Type (2021-2026) & (US$ Million) Table 25. Nedaplatin Injection Industry Trends Table 26. Nedaplatin Injection Industry Drivers Table 27. Nedaplatin Injection Industry Opportunities and Challenges Table 28. Nedaplatin Injection Industry Restraints Table 29. Global Nedaplatin Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Nedaplatin Injection Revenue Market Share by Company (2021-2026) Table 31. Global Nedaplatin Injection Sales by Company (2021-2026) & (K Units) Table 32. Global Nedaplatin Injection Sales Share by Company (2021-2026) Table 33. Global Nedaplatin Injection Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Nedaplatin Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Nedaplatin Injection Major Company Production Sites and Headquarters Table 36. Global Nedaplatin Injection Company, Product Type & Application Table 37. Global Nedaplatin Injection Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Nedaplatin Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Nedaplatin Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Nedaplatin Injection Sales by Region (2021-2026) & (K Units) Table 42. Global Nedaplatin Injection Sales Market Share in Volume by Region (2021-2026) Table 43. Global Nedaplatin Injection Sales by Region (2021-2026) & (US$ Million) Table 44. Global Nedaplatin Injection Sales Market Share in Value by Region (2021-2026) Table 45. Global Nedaplatin Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Nedaplatin Injection Sales by Region (2027-2032) & (K Units) Table 47. Global Nedaplatin Injection Sales Market Share in Volume by Region (2027-2032) Table 48. Global Nedaplatin Injection Sales by Region (2027-2032) & (US$ Million) Table 49. Global Nedaplatin Injection Sales Market Share in Value by Region (2027-2032) Table 50. Global Nedaplatin Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Nedaplatin Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Nedaplatin Injection Sales by Application (2021-2026) & (K Units) Table 53. Global Nedaplatin Injection Sales Market Share in Volume by Application (2021-2026) Table 54. Global Nedaplatin Injection Sales by Application (2021-2026) & (US$ Million) Table 55. Global Nedaplatin Injection Sales Market Share in Value by Application (2021-2026) Table 56. Global Nedaplatin Injection Price by Application (2021-2026) & (US$/Unit) Table 57. Global Nedaplatin Injection Sales by Application (2027-2032) & (K Units) Table 58. Global Nedaplatin Injection Sales Market Share in Volume by Application (2027-2032) Table 59. Global Nedaplatin Injection Sales by Application (2027-2032) & (US$ Million) Table 60. Global Nedaplatin Injection Sales Market Share in Value by Application (2027-2032) Table 61. Global Nedaplatin Injection Price by Application (2027-2032) & (US$/Unit) Table 62. North America Nedaplatin Injection Sales by Application (2021-2026) & (K Units) Table 63. North America Nedaplatin Injection Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Nedaplatin Injection Sales by Application (2021-2026) & (K Units) Table 65. Europe Nedaplatin Injection Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Nedaplatin Injection Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Nedaplatin Injection Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Nedaplatin Injection Sales by Application (2021-2026) & (K Units) Table 69. Latin America Nedaplatin Injection Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Nedaplatin Injection Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Nedaplatin Injection Sales by Application (2021-2026) & (US$ Million) Table 72. Nichi-Iko Pharmaceutical Company Information Table 73. Nichi-Iko Pharmaceutical Business Overview Table 74. Nichi-Iko Pharmaceutical Nedaplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Nichi-Iko Pharmaceutical Nedaplatin Injection Product Portfolio Table 76. Nichi-Iko Pharmaceutical Recent Development Table 77. Jilin Hengjin Pharmaceutical Company Information Table 78. Jilin Hengjin Pharmaceutical Business Overview Table 79. Jilin Hengjin Pharmaceutical Nedaplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Jilin Hengjin Pharmaceutical Nedaplatin Injection Product Portfolio Table 81. Jilin Hengjin Pharmaceutical Recent Development Table 82. Aosaikang Pharma Company Information Table 83. Aosaikang Pharma Business Overview Table 84. Aosaikang Pharma Nedaplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Aosaikang Pharma Nedaplatin Injection Product Portfolio Table 86. Aosaikang Pharma Recent Development Table 87. Simcere Company Information Table 88. Simcere Business Overview Table 89. Simcere Nedaplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Simcere Nedaplatin Injection Product Portfolio Table 91. Simcere Recent Development Table 92. Qilu Pharma Company Information Table 93. Qilu Pharma Business Overview Table 94. Qilu Pharma Nedaplatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Qilu Pharma Nedaplatin Injection Product Portfolio Table 96. Qilu Pharma Recent Development Table 97. North America Nedaplatin Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 98. North America Nedaplatin Injection Sales by Country (2021-2026) & (K Units) Table 99. North America Nedaplatin Injection Sales Market Share by Country (2021-2026) Table 100. North America Nedaplatin Injection Sales Forecast by Country (2027-2032) & (K Units) Table 101. North America Nedaplatin Injection Sales Market Share Forecast by Country (2027-2032) Table 102. North America Nedaplatin Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 103. North America Nedaplatin Injection Market Size by Country (2021-2026) & (US$ Million) Table 104. North America Nedaplatin Injection Market Share by Country (2021-2026) Table 105. North America Nedaplatin Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 106. North America Nedaplatin Injection Market Share Forecast by Country (2027-2032) Table 107. Europe Nedaplatin Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 108. Europe Nedaplatin Injection Sales by Country (2021-2026) & (K Units) Table 109. Europe Nedaplatin Injection Sales Market Share by Country (2021-2026) Table 110. Europe Nedaplatin Injection Sales Forecast by Country (2027-2032) & (K Units) Table 111. Europe Nedaplatin Injection Sales Market Share Forecast by Country (2027-2032) Table 112. Europe Nedaplatin Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 113. Europe Nedaplatin Injection Market Size by Country (2021-2026) & (US$ Million) Table 114. Europe Nedaplatin Injection Market Share by Country (2021-2026) Table 115. Europe Nedaplatin Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 116. Europe Nedaplatin Injection Market Share Forecast by Country (2027-2032) Table 117. Asia-Pacific Nedaplatin Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 118. Asia-Pacific Nedaplatin Injection Sales by Country (2021-2026) & (K Units) Table 119. Asia-Pacific Nedaplatin Injection Sales Market Share by Country (2021-2026) Table 120. Asia-Pacific Nedaplatin Injection Sales Forecast by Country (2027-2032) & (K Units) Table 121. Asia-Pacific Nedaplatin Injection Sales Market Share Forecast by Country (2027-2032) Table 122. Asia-Pacific Nedaplatin Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. Asia-Pacific Nedaplatin Injection Market Size by Country (2021-2026) & (US$ Million) Table 124. Asia-Pacific Nedaplatin Injection Market Share by Country (2021-2026) Table 125. Asia-Pacific Nedaplatin Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. Asia-Pacific Nedaplatin Injection Market Share Forecast by Country (2027-2032) Table 127. Latin America Nedaplatin Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 128. Latin America Nedaplatin Injection Sales by Country (2021-2026) & (K Units) Table 129. Latin America Nedaplatin Injection Sales Market Share by Country (2021-2026) Table 130. Latin America Nedaplatin Injection Sales Forecast by Country (2027-2032) & (K Units) Table 131. Latin America Nedaplatin Injection Sales Market Share Forecast by Country (2027-2032) Table 132. Latin America Nedaplatin Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Latin America Nedaplatin Injection Market Size by Country (2021-2026) & (US$ Million) Table 134. Latin America Nedaplatin Injection Market Share by Country (2021-2026) Table 135. Latin America Nedaplatin Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Latin America Nedaplatin Injection Market Share Forecast by Country (2027-2032) Table 137. Middle East and Africa Nedaplatin Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 138. Middle East and Africa Nedaplatin Injection Sales by Country (2021-2026) & (K Units) Table 139. Middle East and Africa Nedaplatin Injection Sales Market Share by Country (2021-2026) Table 140. Middle East and Africa Nedaplatin Injection Sales Forecast by Country (2027-2032) & (K Units) Table 141. Middle East and Africa Nedaplatin Injection Sales Market Share Forecast by Country (2027-2032) Table 142. Middle East and Africa Nedaplatin Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Middle East and Africa Nedaplatin Injection Market Size by Country (2021-2026) & (US$ Million) Table 144. Middle East and Africa Nedaplatin Injection Market Share by Country (2021-2026) Table 145. Middle East and Africa Nedaplatin Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Middle East and Africa Nedaplatin Injection Market Share Forecast by Country (2027-2032) Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. Nedaplatin Injection Distributors List Table 150. Nedaplatin Injection Customers List Table 151. Research Programs/Design for This Report Table 152. Authors List of This Report Table 153. Secondary Sources Table 154. Primary Sources List of Figures Figure 1. Nedaplatin Injection Image Figure 2. Global Nedaplatin Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nedaplatin Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Nedaplatin Injection Sales (2021-2032) & (K Units) Figure 5. 10mg Image Figure 6. Global 10mg Sales YoY Growth (2021-2032) & (K Units) Figure 7. 50mg Image Figure 8. Global 50mg Sales YoY Growth (2021-2032) & (K Units) Figure 9. 100mg Image Figure 10. Global 100mg Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Nedaplatin Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Nedaplatin Injection Market Share by Type 2025 VS 2032 Figure 13. North America Nedaplatin Injection Sales Market Share in Volume by Type in 2025 Figure 14. North America Nedaplatin Injection Sales Market Share in Value by Type in 2025 Figure 15. Europe Nedaplatin Injection Sales Market Share in Volume by Type in 2025 Figure 16. Europe Nedaplatin Injection Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Nedaplatin Injection Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Nedaplatin Injection Sales Market Share in Value by Type in 2025 Figure 19. Latin America Nedaplatin Injection Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Nedaplatin Injection Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Nedaplatin Injection Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Nedaplatin Injection Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Nedaplatin Injection Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Cervical Cancer Image Figure 26. Global Cervical Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 27. Esophageal Cancer Image Figure 28. Global Esophageal Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 29. Ovarian Cancer Image Figure 30. Global Ovarian Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 31. Testicular Cancer Image Figure 32. Global Testicular Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 33. Lung Cancer Image Figure 34. Global Lung Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 35. Bladder Cancer Image Figure 36. Global Bladder Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 37. Other Image Figure 38. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 39. Global Nedaplatin Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Nedaplatin Injection Market Share by Application 2025 VS 2032 Figure 41. North America Nedaplatin Injection Sales Market Share in Volume by Application in 2025 Figure 42. North America Nedaplatin Injection Sales Market Share in Value by Application in 2025 Figure 43. Europe Nedaplatin Injection Sales Market Share in Volume by Application in 2025 Figure 44. Europe Nedaplatin Injection Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Nedaplatin Injection Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Nedaplatin Injection Sales Market Share in Value by Application in 2025 Figure 47. Latin America Nedaplatin Injection Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Nedaplatin Injection Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Nedaplatin Injection Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Nedaplatin Injection Sales Market Share in Value by Application in 2025 Figure 51. North America Nedaplatin Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. North America Nedaplatin Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Nedaplatin Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Nedaplatin Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Nedaplatin Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Europe Nedaplatin Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Nedaplatin Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Nedaplatin Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Nedaplatin Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Asia-Pacific Nedaplatin Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Nedaplatin Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Nedaplatin Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Nedaplatin Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Latin America Nedaplatin Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Nedaplatin Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Nedaplatin Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Nedaplatin Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 68. Middle East and Africa Nedaplatin Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Nedaplatin Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Nedaplatin Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Nedaplatin Injection Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Nedaplatin Injection Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • 10mg
  • 50mg
  • 100mg
Applications
  • Cervical Cancer
  • Esophageal Cancer
  • Ovarian Cancer
  • Testicular Cancer
  • Lung Cancer
  • Bladder Cancer
  • Other
Companies covered
  • Nichi-Iko Pharmaceutical
  • Jilin Hengjin Pharmaceutical
  • Aosaikang Pharma
  • Simcere
  • Qilu Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Nedaplatin Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Nedaplatin Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Nedaplatin Injection Market by Type
  6. 1.3.1 10mg
  7. 1.3.2 50mg
  8. 1.3.3 100mg
  9. 1.4 Global Nedaplatin Injection Market Size by Type
  10. 1.4.1 Global Nedaplatin Injection Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Nedaplatin Injection Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Nedaplatin Injection Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Nedaplatin Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Nedaplatin Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Nedaplatin Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Nedaplatin Injection Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Nedaplatin Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Nedaplatin Injection Industry Trends
  2. 2.2 Nedaplatin Injection Industry Drivers
  3. 2.3 Nedaplatin Injection Industry Opportunities and Challenges
  4. 2.4 Nedaplatin Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Nedaplatin Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Nedaplatin Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Nedaplatin Injection Price (2021-2026)
  4. 3.4 Global Nedaplatin Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Nedaplatin Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Nedaplatin Injection Company, Product Type & Application
  7. 3.7 Global Nedaplatin Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Nedaplatin Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Nedaplatin Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Nedaplatin Injection Tier 1, Tier 2, and Tier 3
4 Nedaplatin Injection Regional Status and Outlook
  1. 4.1 Global Nedaplatin Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Nedaplatin Injection Historic Market Size by Region
  3. 4.2.1 Global Nedaplatin Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Nedaplatin Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Nedaplatin Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Nedaplatin Injection Forecasted Market Size by Region
  7. 4.3.1 Global Nedaplatin Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Nedaplatin Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Nedaplatin Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Nedaplatin Injection by Application
  1. 5.1 Nedaplatin Injection Market by Application
  2. 5.1.1 Cervical Cancer
  3. 5.1.2 Esophageal Cancer
  4. 5.1.3 Ovarian Cancer
  5. 5.1.4 Testicular Cancer
  6. 5.1.5 Lung Cancer
  7. 5.1.6 Bladder Cancer
  8. 5.1.7 Other
  9. 5.2 Global Nedaplatin Injection Market Size by Application
  10. 5.2.1 Global Nedaplatin Injection Market Size Overview by Application (2021-2032)
  11. 5.2.2 Global Nedaplatin Injection Historic Market Size Review by Application (2021-2026)
  12. 5.2.3 Global Nedaplatin Injection Forecasted Market Size by Application (2027-2032)
  13. 5.3 Key Regions Market Size by Application
  14. 5.3.1 North America Nedaplatin Injection Sales Breakdown by Application (2021-2026)
  15. 5.3.2 Europe Nedaplatin Injection Sales Breakdown by Application (2021-2026)
  16. 5.3.3 Asia-Pacific Nedaplatin Injection Sales Breakdown by Application (2021-2026)
  17. 5.3.4 South America Nedaplatin Injection Sales Breakdown by Application (2021-2026)
  18. 5.3.5 Middle East and Africa Nedaplatin Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Nichi-Iko Pharmaceutical
  2. 6.1.1 Nichi-Iko Pharmaceutical Company Information
  3. 6.1.2 Nichi-Iko Pharmaceutical Business Overview
  4. 6.1.3 Nichi-Iko Pharmaceutical Nedaplatin Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Nichi-Iko Pharmaceutical Nedaplatin Injection Product Portfolio
  6. 6.1.5 Nichi-Iko Pharmaceutical Recent Developments
  7. 6.2 Jilin Hengjin Pharmaceutical
  8. 6.2.1 Jilin Hengjin Pharmaceutical Company Information
  9. 6.2.2 Jilin Hengjin Pharmaceutical Business Overview
  10. 6.2.3 Jilin Hengjin Pharmaceutical Nedaplatin Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Jilin Hengjin Pharmaceutical Nedaplatin Injection Product Portfolio
  12. 6.2.5 Jilin Hengjin Pharmaceutical Recent Developments
  13. 6.3 Aosaikang Pharma
  14. 6.3.1 Aosaikang Pharma Company Information
  15. 6.3.2 Aosaikang Pharma Business Overview
  16. 6.3.3 Aosaikang Pharma Nedaplatin Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Aosaikang Pharma Nedaplatin Injection Product Portfolio
  18. 6.3.5 Aosaikang Pharma Recent Developments
  19. 6.4 Simcere
  20. 6.4.1 Simcere Company Information
  21. 6.4.2 Simcere Business Overview
  22. 6.4.3 Simcere Nedaplatin Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Simcere Nedaplatin Injection Product Portfolio
  24. 6.4.5 Simcere Recent Developments
  25. 6.5 Qilu Pharma
  26. 6.5.1 Qilu Pharma Company Information
  27. 6.5.2 Qilu Pharma Business Overview
  28. 6.5.3 Qilu Pharma Nedaplatin Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Qilu Pharma Nedaplatin Injection Product Portfolio
  30. 6.5.5 Qilu Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Nedaplatin Injection Sales by Country
  2. 7.1.1 North America Nedaplatin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Nedaplatin Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Nedaplatin Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Nedaplatin Injection Market Size by Country
  6. 7.2.1 North America Nedaplatin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Nedaplatin Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Nedaplatin Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Nedaplatin Injection Sales by Country
  2. 8.1.1 Europe Nedaplatin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Nedaplatin Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Nedaplatin Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Nedaplatin Injection Market Size by Country
  6. 8.2.1 Europe Nedaplatin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Nedaplatin Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Nedaplatin Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Nedaplatin Injection Sales by Country
  2. 9.1.1 Asia-Pacific Nedaplatin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Nedaplatin Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Nedaplatin Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Nedaplatin Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Nedaplatin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Nedaplatin Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Nedaplatin Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Nedaplatin Injection Sales by Country
  2. 10.1.1 South America Nedaplatin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Nedaplatin Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Nedaplatin Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Nedaplatin Injection Market Size by Country
  6. 10.2.1 South America Nedaplatin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Nedaplatin Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Nedaplatin Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Nedaplatin Injection Sales by Country
  2. 11.1.1 Middle East and Africa Nedaplatin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Nedaplatin Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Nedaplatin Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Nedaplatin Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Nedaplatin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Nedaplatin Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Nedaplatin Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Nedaplatin Injection Value Chain Analysis
  2. 12.1.1 Nedaplatin Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Nedaplatin Injection Production Mode & Process
  7. 12.2 Nedaplatin Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Nedaplatin Injection Distributors
  10. 12.2.3 Nedaplatin Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst